Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

MMSET I Acts As an Oncoprotein and Regulates GLO1 Expression in T(4;14) Multiple Myeloma Cells

Zhigang Xie, PhD, Jing Yuan Chooi, BSc, Sabrina Hui Min Toh, Bachelor, Wee Joo Chng, MB ChB, MRCP, PhD

Blood (2017) 130 (Supplement 1): 563.

https://doi.org/10.1182/blood.V130.Suppl_1.563.563

Published: 2017

Journal Articles

Metabolic Shift In Hypoxia-Adapted CML Cells and Mechanisms Of Acquired Dasatinib Resistance Uncovered By Proteomic iTRAQ Profiling

Yoko Tabe, MD, PhD, Linhua Jin, PhD, Hiroko Iwanami, Hiromichi Matsushita, MD, PhD, Saiko Kazuno, Tsutomu Fujimura, Takashi Ueno, Takashi Miida, MD, PhD, Michael Andreeff, MD, PhD, Marina Konopleva, MD, PhD, Shinya Kimura, MD, PhD

Blood (2013) 122 (21): 3991.

https://doi.org/10.1182/blood.V122.21.3991.3991

Published: 2013

Journal Articles

A Plant Triterpenoid Avicin D Stimulates Adipocytic Differentiation of Bone Marrow Stromal Cells and Promotes Their Pro-Survival Effects On Acute Monoblastic Leukemia Cells

Yoko Tabe, MD, PhD, Linhua Jin, PhD, Saiko Kazuno, Tsutomu Fujimura, Hiromichi Matsushita, MD, PhD, Takashi Ueno, Michael Andreeff, MD, PhD, Jordan U. Gutterman, MD, Marina Konopleva, MD, PhD

Blood (2012) 120 (21): 4315.

https://doi.org/10.1182/blood.V120.21.4315.4315

Published: 2012

Journal Articles

Hypoxia-Adapted CML Cells Are More Primitive Population and Are Eradicated by Glyoxalase-1 Inhibitors.

Miki Takeuchi, MD, Shinya Kimura, MD, PhD, Junya Kuroda, MD, PhD, Eishi Ashihara, MD, PhD, Makoto Kawatani, PhD, Hiroyuki Osada, PhD, Kazuo Umezawa, PhD, Eiko Yasui, PhD, Masaya Imoto, PhD, Takashi Tsuruo, MD, PhD, Asumi Yokota, MMSc, Ruriko Tanaka, MMSc, Rina Nagao, Tatsutoshi Nakahata, M.D., Ph.D., Yoshihide Fujiyama, MD, PhD, Taira Maekawa, MD, PhD

Blood (2009) 114 (22): 2166.

https://doi.org/10.1182/blood.V114.22.2166.2166

Published: 2009

Journal Articles

Glyoxalase-I Inhibition Eliminates Hypoxia-Adapted CML Cells Resistant to Imatinib, Dasatinib, and INNO-406

Miki Takeuchi, MD, Shinya Kimura, MD, PhD, Junya Kuroda, MD, PhD, Takashi Ushiki, MD, Makoto Kawatani, PhD, Hiroyuki Osada, PhD, Kazuo Umezawa, PhD, Eiko Yasui, PhD, Masaya Imoto, PhD, Takashi Tsuruo, MD, PhD, Keiko Hodohara, MD, PhD, Tatsutoshi Nakahata, MD, PhD, Yoshihide Fujiyama, MD, PhD, Taira Maekawa, MD, PhD

Blood (2008) 112 (11): 3185.

https://doi.org/10.1182/blood.V112.11.3185.3185

Published: 2008

Journal Articles

A Novel β-catenin Inhibitor, AV65 Suppresses the Growth of CML Cell Lines Which Acquire Imatinib-Resistance Because of Abl Kinase Domain Mutations Including T315I and Hypoxia-Adaptation.

Rina Nagao, Shinya Kimura, MD, PhD, Eishi Ashihara, MD, PhD, Miki Takeuchi, MD, Ruriko Tanaka, MMSc, Asumi Yokota, MMSc, Hisayuki Yao, MD, Jeffrey W Strovel, Wieslaw M Cholody, Taira Maekawa, MD, PhD

Blood (2008) 112 (11): 1081.

https://doi.org/10.1182/blood.V112.11.1081.1081

Published: 2008

Journal Articles

Glyoxalase-I Is a Potential Therapeutic Target for Chronic Myelogenous Leukemia Cells That Have Acquired Drug Resistance through Adaptation to Hypoxia.

Miki Takeuchi, Junya Kuroda, Shinya Kimura, Eishi Ashihara, Kazuo Umezawa, Eiko Yasui, Makoto Kawatani, Hiroyuki Osada, Keiko Hodohara, Yoshihide Fujiyama, Taira Maekawa

Blood (2007) 110 (11): 2931.

https://doi.org/10.1182/blood.V110.11.2931.2931

Published: 2007

Journal Articles

Plasma Cell Gene-Expression Profiles in Patients with Systemic AL Amyloidosis: Responses to Melphalan and Stem Cell Transplant Are Associated with Differential Expression of Genes Involved in Translation, Protein Degradation and Detoxification.

Raymond L. Comenzo, MD, Ping Zhou, MD, PhD, Limin Wang, PhD, Stephen D. Nimer, MD, Adam B. Olshen, PhD

Blood (2005) 106 (11): 3405.

https://doi.org/10.1182/blood.V106.11.3405.3405

Published: 2005

Journal Articles

Glyoxalase I is involved in resistance of human leukemia cells to antitumor agent-induced apoptosis

Hiroshi Sakamoto, Tetsuo Mashima, Atsuo Kizaki, Shingo Dan, Yuichi Hashimoto, Mikihiko Naito, Takashi Tsuruo

Blood (2000) 95 (10): 3214–3218.

https://doi.org/10.1182/blood.V95.10.3214

Published: 2000

NARROW

MMSET I Acts As an Oncoprotein and Regulates GLO1 Expression in T(4;14) Multiple Myeloma Cells

Metabolic Shift In Hypoxia-Adapted CML Cells and Mechanisms Of Acquired Dasatinib Resistance Uncovered By Proteomic iTRAQ Profiling

A Plant Triterpenoid Avicin D Stimulates Adipocytic Differentiation of Bone Marrow Stromal Cells and Promotes Their Pro-Survival Effects On Acute Monoblastic Leukemia Cells

Hypoxia-Adapted CML Cells Are More Primitive Population and Are Eradicated by Glyoxalase-1 Inhibitors.

Glyoxalase-I Inhibition Eliminates Hypoxia-Adapted CML Cells Resistant to Imatinib, Dasatinib, and INNO-406

A Novel β-catenin Inhibitor, AV65 Suppresses the Growth of CML Cell Lines Which Acquire Imatinib-Resistance Because of Abl Kinase Domain Mutations Including T315I and Hypoxia-Adaptation.

Glyoxalase-I Is a Potential Therapeutic Target for Chronic Myelogenous Leukemia Cells That Have Acquired Drug Resistance through Adaptation to Hypoxia.

Plasma Cell Gene-Expression Profiles in Patients with Systemic AL Amyloidosis: Responses to Melphalan and Stem Cell Transplant Are Associated with Differential Expression of Genes Involved in Translation, Protein Degradation and Detoxification.

Glyoxalase I is involved in resistance of human leukemia cells to antitumor agent-induced apoptosis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only